SIRT7 Antikörper (AA 242-379)

Produktnummer ABIN7160866

Produktdetails anti-SIRT7 Antikörper

Target: SIRT7 (Sirtuin 7 (SIRT7))

Bindungsspezifität: AA 242-379

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SIRT7 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human NAD-dependent protein deacetylase sirtuin-7 protein (242-379AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu SIRT7

Target: SIRT7 (Sirtuin 7 (SIRT7))

Andere Bezeichnung: SIRT7 (SIRT7 Produkte)

Synonyme: SIRT7 antikoerper, LOC796135 antikoerper, SIR2L7 antikoerper, sirtuin 7 antikoerper, phosphate cytidylyltransferase 2, ethanolamine antikoerper, SIRT7 antikoerper, sirt7 antikoerper, PCYT2 antikoerper, Sirt7 antikoerper

Hintergrund:

Background: NAD-dependent protein deacetylase that specifically mediates deacetylation of histone H3 at \'Lys-18\' (H3K18Ac). In contrast to other histone deacetylases, displays selectivity for a single histone mark, H3K18Ac, directly linked to control of gene expression. H3K18Ac is mainly present around the transcription start site of genes and has been linked to activation of nuclear hormone receptors. SIRT7 thereby acts as a transcription repressor. Moreover, H3K18 hypoacetylation has been reported as a marker of malignancy in various cancers and seems to maintain the transformed phenotype of cancer cells. These data suggest that SIRT7 may play a key role in oncogenic transformation by suppresses expression of tumor suppressor genes by locus-specific deacetylation of H3K18Ac at promoter regions. Also required to restore the transcription of ribosomal RNA (rRNA) at the exit from mitosis: promotes the association of RNA polymerase I with the rDNA promoter region and coding region. Stimulates transcription activity of the RNA polymerase I complex. May also deacetylate p53/TP53 and promotes cell survival, however such data need additional confirmation.

Aliases: NAD dependent deacetylase sirtuin 7 antibody, NAD dependent protein deacetylase sirtuin 7 antibody, NAD-dependent protein deacetylase sirtuin-7 antibody, Regulatory protein SIR2 homolog 7 antibody, Silent mating type information regulation 2 homolog antibody, Silent mating type information regulation 2 S.cerevisiae homolog 7 antibody, SIR2 L7 antibody, SIR2 like protein 7 antibody, Sir2 related protein type 7 antibody, SIR2, S.CEREVISIAE, HOMOLOG-LIKE 7 antibody, SIR2-like protein 7 antibody, SIR2L 7 antibody, SIR2L7 antibody, SIR7_HUMAN antibody, SIRT 7 antibody, SIRT7 antibody, Sirtuin 7 antibody, Sirtuin type 7 antibody, Sirtuin7 antibody

UniProt: Q9NRC8